PPA
ZNTL icon

Parametric Portfolio Associates’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Parametric Portfolio Associates’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$422K Sell
9,156
-6,383
-41% -$344K ﹤0.01% 3162
2021
Q4 		$1.31M Buy
15,539
+2,014
+15% +$156K ﹤0.01% 2669
2021
Q3 		$901K Sell
13,525
-413
-3% -$23.8K ﹤0.01% 2842
2021
Q2 		$742K Buy
13,938
+4,923
+55% +$264K ﹤0.01% 2909
2021
Q1 		$391K Buy
+9,015
New +$388K ﹤0.01% 3607

Other funds holding ZNTL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return